-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: iHuPBMC-B Platform Main Features
Author:
InnoModels
Release time:
2024-03-26
The iHuPBMC-B platform launched by InnoModels Biotechnology is gradually becoming an important tool for cell biology research due to its unique technical features, wide range of application areas and excellent scientific value.
1. Highly reproducible human environment
One of the core advantages of iHuPBMC-B platform is its highly reproducible human environment. The platform utilizes advanced cell culture technology and precise regulatory tools to simulate the complex physiological environment in the human body, including cell-cell interactions, signal transduction, and so on. This enables researchers to more realistically simulate and study cell biological processes in the human body in an in vitro environment.
2. Diverse cell types
The iHuPBMC-B platform provides a diverse selection of cell types. Researchers can choose different types of cells for culture and research according to their experimental needs. This not only broadens the scope of research, but also provides researchers with a more flexible choice of cell models.
3. Efficient cell culture and screening technology
The iHuPBMC-B platform adopts highly efficient cell culture and screening technologies. By optimizing cell culture conditions and improving cell viability and activity, the platform is able to quickly screen cells that meet experimental requirements, greatly improving the efficiency and success rate of experiments.

4. Reliable data support and reproducibility
InnoModels Biotechnology focuses on the reliability of data and repeatability of experiments. iHuPBMC-B platform has gone through strict experimental validation and data analysis during the design and development process to ensure the accuracy and reliability of experimental results. This provides solid data support for researchers and promotes the transformation and application of research results.
5. Wide range of application areas
The iHuPBMC-B platform has a wide range of applications. Whether in drug screening, disease simulation or basic cell biology research, the platform can provide strong support for researchers. It can not only be used to evaluate the efficacy and safety of drugs, but also simulate the occurrence and development of diseases, providing important clues for the research and treatment of diseases.
6. Strong technical support and services
InnoModels Biotechnology provides strong technical support and high quality service. From platform use to data analysis, the company can provide comprehensive help and support for researchers. This provides researchers with great convenience and protection when using the iHuPBMC-B platform.
Conclusion
The iHuPBMC-B platform of InnoModels Biotechnology is becoming an important tool for cell biology research with its highly restored human environment, diverse cell type selection, efficient cell culture and screening technology, reliable data support and reproducibility, wide range of application areas, and strong technical support and services. With the continuous development and improvement of the platform, we have reason to believe that it will play an even more important role in future cell biology research and make greater contributions to the cause of human health.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd